Cargando…
Fibroblast Growth Factor‐23 Concentration in Dogs with Chronic Kidney Disease
BACKGROUND: Chronic kidney disease (CKD) is associated with hyperphosphatemia, decreased vitamin D metabolite concentrations, and hyperparathyroidism. This syndrome is known as CKD‐mineral bone disorder (CKD‐MBD). Recently, it has been shown that an increase in fibroblast growth factor‐23 (FGF‐23) c...
Autores principales: | Harjes, L.M., Parker, V.J., Dembek, K., Young, G.S., Giovaninni, L.H., Kogika, M.M., Chew, D.J., Toribio, R.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435078/ https://www.ncbi.nlm.nih.gov/pubmed/28419560 http://dx.doi.org/10.1111/jvim.14707 |
Ejemplares similares
-
Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor‐23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease
por: Parker, V.J., et al.
Publicado: (2017) -
Factors associated with survival in dogs with chronic kidney disease
por: Rudinsky, Adam J., et al.
Publicado: (2018) -
Short‐term efficacy of epidural pain management in dogs undergoing cystoscopy
por: Rayhel, Laura H., et al.
Publicado: (2021) -
Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
por: Miyakawa, Hirosumi, et al.
Publicado: (2021) -
Fibroblast growth factor 23 and symmetric dimethylarginine concentrations in geriatric cats
por: Sargent, Hannah J., et al.
Publicado: (2019)